Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Przystal JM"'
Autor:
Przystal JM, Waramit S, Pranjol MZI, Yan W, Chu G, Chongchai A, Samarth G, Gene-Olaciregui N, Tabatabai G, Carcaboso AM, Aboagye EO, Suwan K, Hajitou A
Publikováno v:
EMBO Molecular Medicine
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Glioblastoma multiforme (GBM) is the most lethal primary intracranial malignant neoplasm in adults and most resistant to treatment. Integration of gene therapy and chemotherapy, chemovirotherapy, has the potential to improve treatment. We have introd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::774bafb168631c792a1377060d4b8231
http://hdl.handle.net/10044/1/67412
http://hdl.handle.net/10044/1/67412
Autor:
Przystal, JM, Hajji, N, Khozoie, C, Renziehausen, A, Zeng, Q, Abaitua, F, Hajitou, A, Suwan, K, Want, E, Bomalaski, J, Szlosarek, P, O'Neill, K, Crook, T, Syed, N
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 9, Iss 12, Pp 1-10 (2018)
Cell Death and Disease, Vol 9, Iss 12, Pp 1-10 (2018)
Glioblastoma multiforme (GBM) remains a cancer with a poor prognosis and few effective therapeutic options. Successful medical management of GBM is limited by the restricted access of drugs to the central nervous system (CNS) caused by the blood brai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c296c17bc2d31f218b33cd1352dbdb3c
http://hdl.handle.net/10044/1/65835
http://hdl.handle.net/10044/1/65835
Autor:
Becker H; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tubingen, 72072 Tubingen, Germany.; Department of Neurosurgery, University Hospital Tubingen, Eberhard Karls University Tubingen, 72072 Tubingen, Germany., Castaneda-Vega S; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, 72072 Tubingen, Germany.; Department of Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University Tuebingen, 72072 Tubingen, Germany., Patzwaldt K; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, 72072 Tubingen, Germany., Przystal JM; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tubingen, 72072 Tubingen, Germany.; German Translational Cancer Consortium (DKTK), DKFZ Partner Site, 72072 Tubingen, Germany., Walter B; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tubingen, 72072 Tubingen, Germany., Michelotti FC; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, 72072 Tubingen, Germany., Canjuga D; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tubingen, 72072 Tubingen, Germany., Tatagiba M; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tubingen, 72072 Tubingen, Germany.; Department of Neurosurgery, University Hospital Tubingen, Eberhard Karls University Tubingen, 72072 Tubingen, Germany., Pichler B; Department of Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University Tuebingen, 72072 Tubingen, Germany.; German Translational Cancer Consortium (DKTK), DKFZ Partner Site, 72072 Tubingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University, 72072 Tubingen, Germany., Beck SC; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tubingen, 72072 Tubingen, Germany., Holland EC; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, DC 98109, USA., la Fougère C; Department of Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University Tuebingen, 72072 Tubingen, Germany.; German Translational Cancer Consortium (DKTK), DKFZ Partner Site, 72072 Tubingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University, 72072 Tubingen, Germany., Tabatabai G; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tubingen, 72072 Tubingen, Germany.; German Translational Cancer Consortium (DKTK), DKFZ Partner Site, 72072 Tubingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University, 72072 Tubingen, Germany.
Publikováno v:
Brain sciences [Brain Sci] 2022 Oct 24; Vol. 12 (11). Date of Electronic Publication: 2022 Oct 24.
Autor:
Przystal JM; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Cianciolo Cosentino C; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Yadavilli S; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.; Research Center for Genetic Medicine, Children's National Hospital, Washington, DC, USA., Zhang J; Department of Neurology, University of California, San Francisco, San Francisco, California, USA., Laternser S; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Bonner ER; Research Center for Genetic Medicine, Children's National Hospital, Washington, DC, USA., Prasad R; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Dawood AA; Research Center for Genetic Medicine, Children's National Hospital, Washington, DC, USA., Lobeto N; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Chin Chong W; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia and Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., Biery MC; The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA., Myers C; The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA., Olson JM; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Panditharatna E; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Kritzer B; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Mourabit S; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Vitanza NA; The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Washington, Seattle, Washington, USA., Filbin MG; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., de Iuliis GN; Reproductive Science Group, College of Engineering, Science and Environment, University of Newcastle, Callaghan, New South Wales, Australia., Dun MD; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, Hunter Medical Research Institute, University of Newcastle, Callaghan, New South Wales, Australia., Koschmann C; Department of Pediatrics, Michigan Medicine, Ann Arbor, Michigan, USA., Cain JE; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia and Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., Grotzer MA; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Waszak SM; Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo, Oslo, Norway., Mueller S; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.; Department of Pediatrics and Neurosurgery, University of California, San Francisco , San Francisco, California, USA.; Department of Neurology, University of California, San Francisco, San Francisco, California, USA., Nazarian J; Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.; Research Center for Genetic Medicine, Children's National Hospital, Washington, DC, USA.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2022 Sep 01; Vol. 24 (9), pp. 1438-1451.
Autor:
Przystal JM; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.; German Translational Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, 72076 Tübingen, Germany., Becker H; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.; German Translational Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, 72076 Tübingen, Germany., Canjuga D; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tübingen, 72076 Tübingen, Germany., Tsiami F; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.; German Translational Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, 72076 Tübingen, Germany., Anderle N; NMI, Natural and Medical Sciences Institute, University of Tübingen, 72770 Reutlingen, Germany., Keller AL; NMI, Natural and Medical Sciences Institute, University of Tübingen, 72770 Reutlingen, Germany., Pohl A; NMI, Natural and Medical Sciences Institute, University of Tübingen, 72770 Reutlingen, Germany., Ries CH; Roche Innovation Center Munich, Oncology Division, Roche Pharmaceutical Research and Early Development, 82377 Penzberg, Germany., Schmittnaegel M; Roche Innovation Center Munich, Oncology Division, Roche Pharmaceutical Research and Early Development, 82377 Penzberg, Germany., Korinetska N; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tübingen, 72076 Tübingen, Germany., Koch M; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tübingen, 72076 Tübingen, Germany., Schittenhelm J; German Translational Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, 72076 Tübingen, Germany.; Institute for Neuropathology, University Hospital Tübingen, 72076 Tübingen, Germany., Tatagiba M; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.; Department of Neurosurgery, University Hospital Tübingen, Eberhard Karls University Tübingen, 72076 Tübingen, Germany., Schmees C; NMI, Natural and Medical Sciences Institute, University of Tübingen, 72770 Reutlingen, Germany., Beck SC; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.; German Translational Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, 72076 Tübingen, Germany., Tabatabai G; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.; German Translational Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, 72076 Tübingen, Germany.
Publikováno v:
Cancers [Cancers (Basel)] 2021 May 15; Vol. 13 (10). Date of Electronic Publication: 2021 May 15.
Autor:
Vitanza NA; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA., Biery MC; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Myers C; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Ferguson E; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Zheng Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Girard EJ; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Przystal JM; University Children's Hospital Zurich, Zurich, Switzerland., Park G; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Noll A; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Molecular and Cellular Biology Graduate Program and Medical Scientist Training Program, University of Washington, Seattle, Washington, USA., Pakiam F; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Winter CA; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Morris SM; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Sarthy J; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Cole BL; Department of Laboratories, Seattle Children's Hospital, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA., Leary SES; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA., Crane C; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA., Lieberman NAP; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA., Mueller S; University Children's Hospital Zurich, Zurich, Switzerland.; University of California San Francisco, San Francisco, California, USA., Nazarian J; University Children's Hospital Zurich, Zurich, Switzerland.; Department of Genetic Medicine Research, Children's National Medical Center, Washington DC, USA., Gottardo R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Statistics, University of Washington, Seattle, Washington, USA., Brusniak MY; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Mhyre AJ; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Olson JM; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2021 Mar 25; Vol. 23 (3), pp. 376-386.
Autor:
Koch MS; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany., Czemmel S; Quantitative Biology Center (QBiC), Eberhard Karls University Tübingen, Tübingen, Germany., Lennartz F; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany., Beyeler S; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.; German Translational Cancer Consortium (DKTK), DKFZ partner site Tübingen, Tübingen, Germany., Rajaraman S; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany., Przystal JM; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.; German Translational Cancer Consortium (DKTK), DKFZ partner site Tübingen, Tübingen, Germany., Govindarajan P; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany., Canjuga D; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany., Neumann M; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany., Rizzu P; German Center for Neurodegenerative Diseases (DZNE), German Center for Neurodegenerative Diseases, Tübingen, Germany., Zwirner S; Department of Internal Medicine VIII, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany., Hoetker MS; Department of Internal Medicine I, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany., Zender L; Department of Internal Medicine VIII, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.; German Translational Cancer Consortium (DKTK), DKFZ partner site Tübingen, Tübingen, Germany., Walter B; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.; German Translational Cancer Consortium (DKTK), DKFZ partner site Tübingen, Tübingen, Germany., Tatagiba M; Department of Neurosurgery, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany., Raineteau O; University of Lyon, Université Claude Bernard Lyon 1, Inserm, Stem Cell and Brain Research Institute U1208, Bron, France., Heutink P; German Center for Neurodegenerative Diseases (DZNE), German Center for Neurodegenerative Diseases, Tübingen, Germany., Nahnsen S; Quantitative Biology Center (QBiC), Eberhard Karls University Tübingen, Tübingen, Germany., Tabatabai G; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.; German Translational Cancer Consortium (DKTK), DKFZ partner site Tübingen, Tübingen, Germany.
Publikováno v:
Neuro-oncology advances [Neurooncol Adv] 2020 Sep 10; Vol. 2 (1), pp. vdaa115. Date of Electronic Publication: 2020 Sep 10 (Print Publication: 2020).
Autor:
Suwan K; Phage Therapy Group, Department of Brain Sciences, Imperial College London, W12 0NN London, United Kingdom., Yata T; Phage Therapy Group, Department of Brain Sciences, Imperial College London, W12 0NN London, United Kingdom., Waramit S; Phage Therapy Group, Department of Brain Sciences, Imperial College London, W12 0NN London, United Kingdom., Przystal JM; Phage Therapy Group, Department of Brain Sciences, Imperial College London, W12 0NN London, United Kingdom., Stoneham CA; Phage Therapy Group, Department of Brain Sciences, Imperial College London, W12 0NN London, United Kingdom., Bentayebi K; Phage Therapy Group, Department of Brain Sciences, Imperial College London, W12 0NN London, United Kingdom., Asavarut P; Phage Therapy Group, Department of Brain Sciences, Imperial College London, W12 0NN London, United Kingdom., Chongchai A; Thailand Excellence Center for Tissue Engineering and Stem Cells, Department of Biochemistry, Faculty of Medicine, Chiang Mai University, 50200 Chiang Mai, Thailand., Pothachareon P; Thailand Excellence Center for Tissue Engineering and Stem Cells, Department of Biochemistry, Faculty of Medicine, Chiang Mai University, 50200 Chiang Mai, Thailand., Lee KY; Department of Aeronautics, Imperial College London, SW7 2AZ London, United Kingdom., Topanurak S; Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, 10400 Bangkok, Thailand., Smith TL; Rutgers Cancer Institute of New Jersey, Newark, NJ 07103.; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ 07103., Gelovani JG; Karmanos Cancer Institute, School of Medicine, Wayne State University, Detroit, MI 48201.; Department of Biomedical Engineering, College of Engineering, Wayne State University, Detroit, MI 48201., Sidman RL; Department of Neurology, Harvard Medical School, Boston, MA 02115; richard_sidman@hms.harvard.edu renata.pasqualini@rutgers.edu wadih.arap@rutgers.edu a.hajitou@imperial.ac.uk., Pasqualini R; Rutgers Cancer Institute of New Jersey, Newark, NJ 07103; richard_sidman@hms.harvard.edu renata.pasqualini@rutgers.edu wadih.arap@rutgers.edu a.hajitou@imperial.ac.uk.; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ 07103., Arap W; Rutgers Cancer Institute of New Jersey, Newark, NJ 07103; richard_sidman@hms.harvard.edu renata.pasqualini@rutgers.edu wadih.arap@rutgers.edu a.hajitou@imperial.ac.uk.; Division of Hematology/Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103., Hajitou A; Phage Therapy Group, Department of Brain Sciences, Imperial College London, W12 0NN London, United Kingdom; richard_sidman@hms.harvard.edu renata.pasqualini@rutgers.edu wadih.arap@rutgers.edu a.hajitou@imperial.ac.uk.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2019 Sep 10; Vol. 116 (37), pp. 18571-18577. Date of Electronic Publication: 2019 Aug 02.
Autor:
Przystal JM; Phage Therapy Group, Division of Brain Sciences, Imperial College London, London, UK.; John Fulcher Neuro-Oncology Laboratory, Division of Brain Sciences, Imperial College London, London, UK., Hajji N; John Fulcher Neuro-Oncology Laboratory, Division of Brain Sciences, Imperial College London, London, UK., Khozoie C; John Fulcher Neuro-Oncology Laboratory, Division of Brain Sciences, Imperial College London, London, UK., Renziehausen A; John Fulcher Neuro-Oncology Laboratory, Division of Brain Sciences, Imperial College London, London, UK., Zeng Q; John Fulcher Neuro-Oncology Laboratory, Division of Brain Sciences, Imperial College London, London, UK., Abaitua F; John Fulcher Neuro-Oncology Laboratory, Division of Brain Sciences, Imperial College London, London, UK., Hajitou A; Phage Therapy Group, Division of Brain Sciences, Imperial College London, London, UK., Suwan K; Phage Therapy Group, Division of Brain Sciences, Imperial College London, London, UK., Want E; Department of Cancer and Surgery, Imperial College, London, UK., Bomalaski J; Polaris Pharmaceuticals Inc., San Diego, California, USA., Szlosarek P; Center for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, UK., O'Neill K; John Fulcher Neuro-Oncology Laboratory, Division of Brain Sciences, Imperial College London, London, UK., Crook T; St Luke's Cancer Centre, Egerton Road, Guildford, UK., Syed N; John Fulcher Neuro-Oncology Laboratory, Division of Brain Sciences, Imperial College London, London, UK. n.syed@imperial.ac.uk.
Publikováno v:
Cell death & disease [Cell Death Dis] 2018 Dec 13; Vol. 9 (12), pp. 1192. Date of Electronic Publication: 2018 Dec 13.
Autor:
Przystal JM; Division of Brain Sciences, Hammersmith Hospital Campus, Department of Medicine, Imperial College London, Burlington Danes Building, 160 Du Cane Road, London W12 0NN, United Kingdom., Umukoro E, Stoneham CA, Yata T, O'Neill K, Syed N, Hajitou A
Publikováno v:
Molecular oncology [Mol Oncol] 2013 Feb; Vol. 7 (1), pp. 55-66. Date of Electronic Publication: 2012 Aug 21.